Private Equity

A new partnership embeds PitchBook's data into Samaya AI, promising auditable insights for finance. Is this the answer to the AI 'black box' problem?

With the hire of Patrick Duffy, Dropzone AI signals a major push in its mission to solve cybersecurity's twin crises with a new breed of AI agents.

A private equity firm just bought a French network company. It's a bigger deal than you think, revealing the new front line of digital security.

In a tough fundraising climate, Clearlake Capital's massive $14.8B close isn't just a win; it's a strategic bet on the AI-driven future of industry.

As AI-driven attacks escalate, BreachRx adds Phil Venables to its board, signaling a critical shift in how enterprises must manage cyber crises.

As AI pushes data centers to their limits, Divcon is betting on new leaders and a 'Grid-to-Chip' vision. Here's why its overhaul is critical for digital infrastructure.

After a disastrous failure, Stephenville's airport has a new owner. BTG Capital's acquisition is more than a local rescue; it's a play on global trade and defence.

With a $5.3 billion backlog and pipeline, Congruex brings in financial heavyweight Jim Stanley to navigate explosive growth and complex market pressures.

Oxford Financial Group's major Cincinnati expansion highlights a national trend: the strategic battle for top talent and regional dominance in wealth management.

Adial Pharmaceuticals pivots from addiction to inflammation, securing $32M and poaching Azora's leadership to drive its new ulcerative colitis drug, AT177.

Innovate 32's partnership with Viridian Dental Partners signals a new wave of consolidation in dentistry, backed by Shore Capital's deep private equity pockets.

New research reveals a stark divide: leaders prioritize R&D while the public and investors demand reinvestment in workers. Who will win the battle for AI's gains?

Tiny biotech HCW Biologics reports promising early data for its alopecia drug. But with a small sample size and big pharma rivals, is this a true breakthrough?

With a third consecutive GigaOm Leader nod, Scale Computing isn't just innovating; it's defining the future of distributed enterprise IT. What's their secret?

A strategic investment in RCM provider Fellow Health Partners reveals a deeper trend: PE firms are now backing high-touch service, not just scalable tech.

J.D. Sitton's move to National signals a broader industry trend: the critical role of veteran IR leaders in navigating a complex real estate market.

With $10M in funding, Magnitude launches an autonomous AI workforce to combat machine-speed threats, forcing a reckoning in third-party risk management.

ZRG's strategic acquisition of Fortium isn't just M&A; it's a major bet on the future of work, where on-demand CIOs and CISOs are the new normal.

Amid GBTG's strong growth and AI push, a law firm's probe into its $9.50/share buyout questions if shareholders are getting a fair deal.

With a major debt financing, French biotech Inventiva is funded through a pivotal Phase 3 trial for its MASH drug, highlighting a strategic shift in biotech funding.